Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy
oleh: Jaspreet Kaur, Ajaykumar Singh, Minit Shah, Pratik Chandrani, Anuradha Chougule, Omshree Shetty, Trupti Pai, Santosh Menon, Subhash Yadav, Akhil Kapoor, B K Mishra, Amit Dutt, Vanita Noronha, Kumar Prabhash
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer Medknow Publications 2023-01-01 |
Deskripsi
No description available for this item.